3,0
17. Sep. 2014
Aktueller Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Good benefiits, satisfaction of working for a company that is developing life-saving medicines.
Kontras
Uncertainty abounds as a result of IT's major reorganization/transformation. Some processes that Medi IT had developed are being replaced by new processes for the global AstraZeneca IT organization. In some instances IT has taken several years worth of steps backwards. There's more uncertainty with the possibility of a takeover by Pfizer.